Pancreatic kininogenase enteric coated tablets have the effect of dilating blood vessels to improve microcirculation. Pancreatic kininogenase enteric-coated tablets can dilate blood vessels, thus improving microcirculation, but also can activate fibrozymes, reduce the viscosity of the blood, prevent platelet aggregation, and avoid the formation of blood clots. It is mainly used in the treatment of microcirculation disorders, and can also be used in the adjuvant treatment of hypertension. Therefore, the drug can improve blood vessels, but after taking it, allergic reactions such as skin rashes, skin itching and stomach discomfort may occur, which will disappear after stopping the drug. It is contraindicated for people with cerebral hemorrhage and acute bleeding disorders. And pregnant and lactating women need to use the drug under doctor’s supervision. If the condition requires long-term treatment with pancreatic kininogenase enteric coated tablets, it is recommended to decide the dosage of the drug after a comprehensive assessment by a doctor, and the specific use of the drug should be in accordance with the doctor’s instructions.